All locations
| Company | Sector & Purpose | Updated | Following |
|---|---|---|---|
|
Amgen
|
Biotechnology
To serve patients by transforming the promise of science and biotechnology into therapies with the potential to restore health or save lives
|
2025-Q3
|
|
|
Medifast
|
Weight Management
To provide scientifically proven weight management and healthy living products through physician-recommended programs
|
2025-Q3
|
|
|
Usana Health Sciences
|
Nutritional Supplements
To develop scientifically based nutritional and personal care products that promote optimal health, wellness and longevity
|
2025-Q3
|
|
|
Amicus Therapeutics
|
Biotechnology
To serve patients, families and caregivers affected by rare and orphan diseases
|
2025-Q3
|
|
|
Adma Biologics
|
Biopharmaceuticals
To manufacture, market and develop specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases
|
2025-Q3
|
|
|
Arcus Biosciences
|
Biotechnology
To develop innovative cancer immunotherapies that transform patient outcomes through precision medicine approaches
|
2025-Q3
|
|
|
Adc Therapeutics Sa
|
Biotechnology
To develop and deliver innovative antibody drug conjugates to transform treatment for cancer patients globally
|
2025-Q3
|
|
|
Arcturus Therapeutics
|
Biotechnology
To advance RNA medicines through innovative messenger RNA and self-amplifying RNA therapeutics to treat rare diseases and vaccines
|
2025-Q3
|
|
|
Absci
|
Biotechnology
To create better biologics through the power of artificial intelligence and synthetic biology
|
2025-Q3
|
|
|
Allogene Therapeutics
|
Biotechnology
To develop transformative allogeneic CAR T cell therapies to treat cancer patients
|
2025-Q3
|
|
|
Arcellx
|
Biotechnology
To develop innovative cell therapies for cancer patients using advanced biotechnology platforms
|
2025-Q3
|
|
|
Herbalife
|
Nutritional supplements
To make the world healthier and happier through nutrition and entrepreneurial opportunity
|
2025-Q3
|
|
|
Altimmune
|
Biotechnology
To develop innovative medicines for obesity, NASH, and metabolic diseases
|
2025-Q3
|
|
|
Apogee Therapeutics
|
Biotechnology
To develop transformative immunology medicines for patients with serious diseases
|
2025-Q3
|